{"columns": ["cmem_t_edit_distance", "cmem_t_is_updated", "cmem_t_memory_len", "cmem_t_memory_str", "cmem_t_memory_str_len"], "data": [[NaN, NaN, 6.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.", 374.0], [100.0, true, 6.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.", 374.0], [100.0, true, 6.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.", 374.0], [63.0, false, 6.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.", 374.0], [88.0, true, 7.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma is considered an invasive carcinoma for T staging purposes.", 472.0], [91.0, true, 7.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma and polymorphocellular undifferentiated breast carcinoma are both considered invasive carcinomas for T staging purposes.", 533.0], [94.0, true, 8.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma and polymorphocellular undifferentiated breast carcinoma are both considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.", 599.0], [93.0, true, 9.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma and polymorphocellular undifferentiated breast carcinoma are both considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive mucinous carcinoma is considered an invasive carcinoma for T staging purposes.", 687.0], [100.0, true, 9.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma and polymorphocellular undifferentiated breast carcinoma are both considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive mucinous carcinoma is considered an invasive carcinoma for T staging purposes.", 687.0], [89.0, true, 8.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, and invasive mucinous carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.", 628.0], [93.0, true, 9.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, and invasive mucinous carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive adenocarcinoma of the breast is a type of invasive carcinoma for T staging purposes.", 722.0], [71.0, false, 9.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, and invasive mucinous carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive adenocarcinoma of the breast is a type of invasive carcinoma for T staging purposes.", 722.0], [92.0, true, 10.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, and invasive duct carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive adenocarcinoma of the breast is a type of invasive carcinoma for T staging purposes.\nLymphovascular invasion does not affect T staging.", 798.0], [100.0, true, 10.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, and invasive duct carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive adenocarcinoma of the breast is a type of invasive carcinoma for T staging purposes.\nLymphovascular invasion does not affect T staging.", 798.0], [100.0, true, 10.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, and invasive duct carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive adenocarcinoma of the breast is a type of invasive carcinoma for T staging purposes.\nLymphovascular invasion does not affect T staging.", 798.0], [100.0, true, 10.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, and invasive duct carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive adenocarcinoma of the breast is a type of invasive carcinoma for T staging purposes.\nLymphovascular invasion does not affect T staging.", 798.0], [96.0, true, 11.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, and invasive duct carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive adenocarcinoma of the breast is a type of invasive carcinoma for T staging purposes.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.", 873.0], [100.0, true, 11.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, and invasive duct carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive adenocarcinoma of the breast is a type of invasive carcinoma for T staging purposes.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.", 873.0], [100.0, true, 11.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, and invasive duct carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive adenocarcinoma of the breast is a type of invasive carcinoma for T staging purposes.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.", 873.0], [95.0, true, 12.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, and invasive duct carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nInvasive adenocarcinoma of the breast is a type of invasive carcinoma for T staging purposes.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma is a type of invasive carcinoma for T staging purposes.", 963.0], [90.0, true, 11.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, and invasive adenocarcinoma of the breast are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma is a type of invasive carcinoma for T staging purposes.", 908.0], [91.0, true, 11.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.", 979.0], [100.0, true, 11.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.", 979.0], [96.0, true, 12.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.", 1054.0], [100.0, true, 12.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.", 1054.0], [90.0, true, 13.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.", 1287.0], [86.0, true, 16.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1689.0], [100.0, true, 16.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1689.0], [100.0, true, 16.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1689.0], [50.0, false, 16.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1689.0], [100.0, true, 16.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1689.0], [100.0, true, 16.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1689.0], [100.0, true, 16.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1689.0], [100.0, true, 16.0, "T1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nT stages are based on the largest tumor size for invasive carcinomas.\nT stages are assigned based on the primary tumor's size and its invasion into surrounding tissues.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1689.0], [93.0, true, 15.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1590.0], [100.0, true, 15.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1590.0], [100.0, true, 15.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1590.0], [100.0, true, 15.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1590.0], [100.0, true, 15.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1590.0], [100.0, true, 15.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.", 1590.0], [98.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1662.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1662.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1662.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1662.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1662.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1662.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1662.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1662.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nTumor size is the primary factor in determining T stage, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall and/or skin.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1662.0], [88.0, true, 18.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nLymphovascular invasion does not affect T staging.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1580.0], [98.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1529.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1529.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1529.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1529.0], [71.0, false, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1529.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1529.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1529.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1529.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1529.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nInvasive micropapillary carcinoma and invasive ductal and lobular carcinoma are types of invasive carcinomas for T staging purposes.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1529.0], [95.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1396.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1396.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1396.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1396.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1396.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1396.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1396.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1396.0], [100.0, true, 16.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.", 1396.0], [97.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0], [100.0, true, 17.0, "T stages are based on the largest tumor size for invasive carcinomas.\nT1: Tumor size is 2.0 cm or less.\nT1a: Tumor size is up to 0.5 cm.\nT1b: Tumor size is more than 0.5 cm but not more than 1 cm.\nT1c: Tumor size is more than 1 cm but not more than 2 cm.\nT2: Tumor size is more than 2.0 cm but not more than 5.0 cm.\nT3: Tumor size is more than 5.0 cm.\nT4: Tumor of any size with direct extension to the chest wall and/or skin.\nInfiltrating papillary adenocarcinoma, polymorphocellular undifferentiated breast carcinoma, invasive mucinous carcinoma, invasive duct carcinoma, invasive adenocarcinoma of the breast, and invasive lobular carcinoma are all considered invasive carcinomas for T staging purposes.\nDirect extension to the chest wall or skin results in a T4 stage.\nThe presence of ductal carcinoma in situ (DCIS) does not affect T staging.\nSub-staging information (such as 'mi' in pN1mi) does not affect T staging.\nThe Nottingham score, nuclear grade, tubule formation, mitotic activity score, and total Nottingham score do not affect T staging.\nThe presence of microcalcifications, fibrocystic changes, skin involvement, non-neoplastic breast tissue, and estrogen and progesterone receptor status do not affect T staging.\nThe method(s) of lymph node examination and sentinel node metastasis do not affect T staging.\nHER2/CEP 17 ratio or HER2 gene amplification does not affect T staging.\nTumor aggregate size or the sum of the sizes of multiple invasive tumors does not affect T staging.", 1496.0]]}